Sign inJoin waitlistJoin the waitlist

HK

Homayoun Khanlou

Medical Affairs Director, HIV/HCV · Merck

Credentials: · · ·

History

Rumi Care Corp · Urgento
2025–Present

Internal Medicine
Jefferson Health Medical Education
1995–1998
Doctor of Medicine
1991–1995

Research

The major genetic determinants of HIV-1 control affect HLA class I peptide presentation
Science · 2010 · 997 citations
Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48
AIDS · 2008 · 319 citations
Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells
Nature Medicine · 2009 · 204 citations

CF
Charles Farthing
13 papers
SS
Shilpa Sayana
12 papers · 3 as a resident
Glenn Eiger
7 papers
ED
Edwin Dejesus
6 papers
JR
Juan Ricaurte
4 papers
GH
Gerald Hamwi
3 papers
Kenneth Rothstein
3 papers
LB
Laveeza Bhatti
3 papers
NK
Negar Khanlou
3 papers · 2 as a resident
CC
Catherine Chien
2 papers
DW
Douglas Ward
2 papers
ED
Eric Daar
2 papers